159 related articles for article (PubMed ID: 31593690)
1. The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by methylene violet 3RAX.
Onder S; Biberoglu K; Tacal O
Chem Biol Interact; 2019 Dec; 314():108845. PubMed ID: 31593690
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cholinesterases by safranin O: Integration of inhibition kinetics with molecular docking simulations.
Onder S; Sari S; Tacal O
Arch Biochem Biophys; 2021 Feb; 698():108728. PubMed ID: 33345803
[TBL] [Abstract][Full Text] [Related]
3. Toluidine blue O is a potent inhibitor of human cholinesterases.
Biberoglu K; Tek MY; Ghasemi ST; Tacal O
Arch Biochem Biophys; 2016 Aug; 604():57-62. PubMed ID: 27296777
[TBL] [Abstract][Full Text] [Related]
4. Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
Chem Biol Interact; 1999 May; 119-120():61-9. PubMed ID: 10421439
[TBL] [Abstract][Full Text] [Related]
5. Discovery of methoxy-naphthyl linked N-(1-benzylpiperidine) benzamide as a blood-brain permeable dual inhibitor of acetylcholinesterase and butyrylcholinesterase.
Abdullaha M; Nuthakki VK; Bharate SB
Eur J Med Chem; 2020 Dec; 207():112761. PubMed ID: 32942070
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of two different cholinesterases by tacrine.
Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
[TBL] [Abstract][Full Text] [Related]
7. Structural aspects of 4-aminoquinolines as reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase.
Bosak A; Opsenica DM; Šinko G; Zlatar M; Kovarik Z
Chem Biol Interact; 2019 Aug; 308():101-109. PubMed ID: 31100281
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in silico analysis of novel astaxanthin-s-allyl cysteine as an inhibitor of butyrylcholinesterase and various globular forms of acetylcholinesterases.
Sakayanathan P; Loganathan C; Kandasamy S; Ramanna RV; Poomani K; Thayumanavan P
Int J Biol Macromol; 2019 Nov; 140():1147-1157. PubMed ID: 31442505
[TBL] [Abstract][Full Text] [Related]
9. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
[TBL] [Abstract][Full Text] [Related]
10. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of acetylcholinesterase and butyrylcholinesterase by chlorpyrifos-oxon.
Amitai G; Moorad D; Adani R; Doctor BP
Biochem Pharmacol; 1998 Aug; 56(3):293-9. PubMed ID: 9744565
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cholinesterase inhibitory activity study of new piperidone grafted spiropyrrolidines.
Basiri A; Abd Razik BM; Ezzat MO; Kia Y; Kumar RS; Almansour AI; Arumugam N; Murugaiyah V
Bioorg Chem; 2017 Dec; 75():210-216. PubMed ID: 28987876
[TBL] [Abstract][Full Text] [Related]
13. Ionic liquid mediated synthesis of mono- and bis-spirooxindole-hexahydropyrrolidines as cholinesterase inhibitors and their molecular docking studies.
Kia Y; Osman H; Kumar RS; Basiri A; Murugaiyah V
Bioorg Med Chem; 2014 Feb; 22(4):1318-28. PubMed ID: 24461561
[TBL] [Abstract][Full Text] [Related]
14. Reversible inhibition of acetylcholinesterase and butyrylcholinesterase by 4,4'-bipyridine and by a coumarin derivative.
Simeon-Rudolf V; Kovarik Z; Radić Z; Reiner E
Chem Biol Interact; 1999 May; 119-120():119-28. PubMed ID: 10421445
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structure-activity relationship and molecular docking of 3-oxoaurones and 3-thioaurones as acetylcholinesterase and butyrylcholinesterase inhibitors.
Mughal EU; Sadiq A; Murtaza S; Rafique H; Zafar MN; Riaz T; Khan BA; Hameed A; Khan KM
Bioorg Med Chem; 2017 Jan; 25(1):100-106. PubMed ID: 27780618
[TBL] [Abstract][Full Text] [Related]
16. Interaction study of two diterpenes, cryptotanshinone and dihydrotanshinone, to human acetylcholinesterase and butyrylcholinesterase by molecular docking and kinetic analysis.
Wong KK; Ngo JC; Liu S; Lin HQ; Hu C; Shaw PC; Wan DC
Chem Biol Interact; 2010 Sep; 187(1-3):335-9. PubMed ID: 20350537
[TBL] [Abstract][Full Text] [Related]
17. Identification of New Chromenone Derivatives as Cholinesterase Inhibitors and Molecular Docking Studies.
Iqbal J; Abbasi MSA; Zaib S; Afridi S; Furtmann N; Bajorath J; Langer P
Med Chem; 2018; 14(8):809-817. PubMed ID: 29473519
[TBL] [Abstract][Full Text] [Related]
18. Molecular and Computational Analysis Identify Statins as Selective Inhibitors of Human Butyrylcholinesterase.
Atay MS; Sari S; Bodur E
Protein J; 2023 Apr; 42(2):104-111. PubMed ID: 36648628
[TBL] [Abstract][Full Text] [Related]
19. 2-Arylbenzofurans from Artocarpus lakoocha and methyl ether analogs with potent cholinesterase inhibitory activity.
Namdaung U; Athipornchai A; Khammee T; Kuno M; Suksamrarn S
Eur J Med Chem; 2018 Jan; 143():1301-1311. PubMed ID: 29126732
[TBL] [Abstract][Full Text] [Related]
20. The interactions of azure B, a metabolite of methylene blue, with acetylcholinesterase and butyrylcholinesterase.
Petzer A; Harvey BH; Petzer JP
Toxicol Appl Pharmacol; 2014 Feb; 274(3):488-93. PubMed ID: 24161345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]